RGEN FY 2019 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

FY 2019 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$270M+39.3% YoY

Gross Profit

$138M51.1% margin

Operating Income

$40M14.8% margin

Net Income

$21M7.9% margin

EPS (Diluted)

$0.44

Cash Flow

Operating Cash Flow

$67M

Free Cash Flow

$44M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$340M

Stockholders' Equity

$1.1B

Cash & Equivalents

$528M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$270M	$194M	+39.3%
Gross Profit	$138M	$108M	+27.9%
Operating Income	$40M	$26M	+54.2%
Net Income	$21M	$17M	+28.8%